|
Monday, 23 March 2009 08:50 |
| Patent number | Description | Assignee | Inventor | Priority application date | Publication date |
|---|
Source: Thomson Scientific Search Service. The status of each application is slightly different from country to country. For further details, contact Thomson Scientific, 1800 Diagonal Road, Suite 250, Alexandria, Virginia 22314, USA. Tel: 1 (800) 337-9368 (http://www.thomson.com/scientific). | | WO 2008112283 | A method of predicting the responsiveness of a tumor to treatment for anti-androgen therapy for prostate cancer by determining the androgen responsiveness microRNA expression profile of the tumor and correlating it to the therapeutic treatment. | US Department of Health and Human Services (Washington, DC, USA) | Kim CH, Munroe D, Soto J, Wu X | 3/12/2007 | 9/18/2008 | | US 20080199871 | A method of determining the sequence of a nucleic acid polymer, comprising forming a complementary strand of the nucleic acid polymer and identifying a sequence of nucleotides in the nucleic acid polymer and/or in the complementary strand using a particle beam, where the nucleic acid polymer and/or the complementary strand is DNA or RNA. | ZS Genetics (Bryn Mawr, PA, USA) | Glover WR | 7/14/2004 | 8/21/2008 | | CN 101246520 | A protein compound identification method involving building a protein interaction un-digraph, inputting a group of protein interaction data and setting a permitted maximum din of a shortest distance between a protein peak and a threshold value tin, which is between 0 to 1. The weight of each edge in a network is calculated, where the edge weight is defined as number of a public neighbor peak of two peaks of the edge. A seed is selected, when a candidate seed queue does not empty, and the seed is expanded as an initial state of an identified protein compound. | Central South University (Changsha, China) | Li M, Wang J | 3/18/2008 | 8/20/2008 | | WO 2008096375 | A method for determining a susceptibility to prostate cancer comprising determining the presence or absence of polymorphic markers in a nucleic acid sample obtained from the individual. | Decode Genetics (Reykjavik, Iceland) | Gudmundsson J, Sulem P | 2/7/2007 | 8/14/2008 | | CN 101234813 | Biologically processing sewage by installing a micropore aeration plate on a barrier, fixing a dynamic film on the barrier and placing a sequencing batch biological film unit on the dynamic film. | Wuhan University of Science and Technology (Wuhan, China) | Li Y, Yao M, Zhang Z | 11/22/2007 | 8/6/2008 | | JP 2008175793 | A method of determining sugar chain arrangement using a mass spectrometer by cleaving sugar chains into fragments, subjecting them to mass spectrometry and comparing various sugar chain fragments spectra or calculated sugar chain arrangement data. | Lifix (Toyama, Japan) | Anyoji H, Kanazawa M | 1/16/2007 | 7/31/2008 | | US 20080166773 | A vector preparation comprising a double-stranded DNA molecule having 3'-termini, useful for preparing recombinant moleculeshaving only a single insert and for cloning PCR-amplified sequences. | Lucigen (Middleton, WI, USA) | Godiska R, Hermanson S, Mead DA, Schoenfeld TW | 1/8/2007 | 7/10/2008 | | WO 2008041002 | Pairwise sequencing of the first and second regions of a target double-stranded polynucleotide by carrying out an extension reaction, treating the first and second immobilized template strands and carrying out a second sequencing read. | Solexa (Saffron Walden, UK) | Fashena S, Ost T, Rigatti R | 10/6/2006 | 4/10/2008 |
|